Citigroup Maintains Buy on Edwards Lifesciences, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Edwards Lifesciences (NYSE:EW) but lowers the price target from $94 to $85.
October 26, 2023 | 3:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Citigroup maintains a Buy rating on Edwards Lifesciences but lowers the price target from $94 to $85.
The news is directly related to Edwards Lifesciences and is likely to impact its stock price. While the maintained Buy rating is positive, the lowered price target may have a negative effect. However, the overall impact is neutral as the lowered price target might already be priced in.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100